Emerging data suggest Retatrutide , a dual stimulator targeting both GLP-1 and another hormone, could provide a promising advancement for obesity loss . Initial human tests have demonstrated considerable decreases more info in body tissue, potentially exceeding current weight-loss therapies . However , further assessment is needed to completely ass